The clinical prediction model is very valuable as it can be applied to a various scenario like screening, prediction, medical decision making and education in health.
The need for a precise and repeatable method for accurately measuring and quantifying the lipoprotein density profile for studies dealing with CVD is necessary for screening, prediction of disease, and possibly monitoring the effectiveness of treatment.
However, after screening the predictions made by these two methods for conservation across the predicted Sec-encoding TGA and potential SECIS elements, all candidates were discarded.
Knowing the differences of the human and plant screening routes, predictions of the applicability of that multi-step process on a commercial database have been explored.
We have used various computational methodologies including molecular dynamics, density functional theory, virtual screening, ADMET predictions and molecular interaction field studies to design and analyze four novel potential inhibitors of farnesyltransferase (FTase).
Structure-based activity models of chemical endocrine disruptors would be very helpful for safety screening and predictions of exposure outcomes (Devillers et al. 2006).
Additionally, the translational capacity of epigenetic biomarker panels may be clinically applicable in screening, diagnosis, prediction of response and prognostication.
A promising approach for early screening and prediction of DDIs is computational modeling.
The three-part sequential processing routine requires: 1) a regressive data-compression preprocessing, 2) a smart-sample generation using general-regression neural networks (GRNN), and 3) a screening power prediction using 'reverse' swarm intelligence (SI).
A study was undertaken aimed at developing a dynamic in vitro method based on the use of artificial membranes for screening and prediction of the absorption properties of drugs.
